Correlation Between Septerna, Common and Eupraxia Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Septerna, Common and Eupraxia Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Septerna, Common and Eupraxia Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Septerna, Common Stock and Eupraxia Pharmaceuticals Common, you can compare the effects of market volatilities on Septerna, Common and Eupraxia Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Septerna, Common with a short position of Eupraxia Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Septerna, Common and Eupraxia Pharmaceuticals.

Diversification Opportunities for Septerna, Common and Eupraxia Pharmaceuticals

0.04

Correlation Coefficient

Septerna, Common  Eupraxia Pharmaceuticals

Significant diversification

The 3 months correlation between Septerna, and Eupraxia is 0.04. Overlapping area represents the amount of risk that can be diversified away by holding Septerna, Common Stock and Eupraxia Pharmaceuticals Commo in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Eupraxia Pharmaceuticals and Septerna, Common is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Septerna, Common Stock are associated (or correlated) with Eupraxia Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Eupraxia Pharmaceuticals has no effect on the direction of Septerna, Common i.e., Septerna, Common and Eupraxia Pharmaceuticals go up and down completely randomly.

Pair Corralation between Septerna, Common and Eupraxia Pharmaceuticals

Given the investment horizon of 90 days Septerna, Common Stock is expected to generate 0.87 times more return on investment than Eupraxia Pharmaceuticals. However, Septerna, Common Stock is 1.15 times less risky than Eupraxia Pharmaceuticals. It trades about 0.07 of its potential returns per unit of risk. Eupraxia Pharmaceuticals Common is currently generating about -0.11 per unit of risk. If you would invest  2,325  in Septerna, Common Stock on September 24, 2024 and sell it today you would earn a total of  103.00  from holding Septerna, Common Stock or generate 4.43% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Septerna, Common Stock  vs.  Eupraxia Pharmaceuticals Commo

Septerna, Common Stock

Risk-Adjusted Performance

12 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Septerna, Common Stock are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. In spite of very weak basic indicators, Septerna, Common displayed solid returns over the last few months and may actually be approaching a breakup point.

Eupraxia Pharmaceuticals

Risk-Adjusted Performance

4 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Eupraxia Pharmaceuticals Common are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, Eupraxia Pharmaceuticals showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Septerna, Common and Eupraxia Pharmaceuticals

The main advantage of trading using opposite Septerna, Common and Eupraxia Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Septerna, Common position performs unexpectedly, Eupraxia Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Eupraxia Pharmaceuticals will offset losses from the drop in Eupraxia Pharmaceuticals' long position.

The idea behind Septerna, Common Stock and Eupraxia Pharmaceuticals Common pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.